![]() |
市場調査レポート
商品コード
1439646
手術用ロボットシステム - 世界市場の考察、競合情勢、市場予測(2030年)Surgical Robotic System - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
||||||
カスタマイズ可能
適宜更新あり
|
手術用ロボットシステム - 世界市場の考察、競合情勢、市場予測(2030年) |
出版日: 2024年02月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の手術用ロボットシステムの市場規模は、2023年に50億2,000万米ドル、2030年までに96億4,000万米ドルに達し、2024年~2030年の予測期間にCAGRで11.50%の成長が見込まれます。手術用ロボットシステムの需要の急増は、前立腺がん、弁膜症、子宮内膜症などのリスク人口の大部分を占める老年人口の増加、低侵襲手術アプローチへの志向の高まりによるロボット支援手術システムのニーズの高まり、小型手術用ロボットへの道を開く製品開発の革新などのさまざまな要因に起因する外科手術の増加によるものであり、結果として2024年~2030年の予測期間における手術用ロボットシステム市場全体の成長に寄与しています。
手術用ロボットシステムの市場力学
手術用ロボットシステム市場は、低侵襲手術の人気の高まりにより製品需要が急増しています。開腹手術は依然として一般的ですが、開腹手術に伴う合併症リスクの増大、治癒時間の長期化などの欠点が、低侵襲手術用ロボットシステム開発のきっかけとなっています。手術用ロボットは、正確性、安定性、最新のイメージング技術との統合、より大きな可動域、遠隔手術、さらにはその他の、各手術分野特有の恩恵をもたらします。内視鏡は開腹手術の限界を克服するのに役立ちましたが、この手法には視線の制限などの課題もありました。da Vinci、AESOP、ZEUSシステムを含むこれらのシステムは、先進技術を利用した視野と技巧を外科医に提供します。その結果、こうしたシステムは手術の分野に革命を起こすと予測されています。このように、医療分野における手術用ロボットの利点により、手術用ロボットシステム市場の成長見通しは、2024年~2030年の予測期間に有利になる見込みです。
さらに、子宮内膜症などの婦人科疾患、前立腺がんなどの泌尿器科疾患、僧帽弁膜症などの心血管疾患などのさまざまな疾患の有病率が上昇していることも、外科的介入件数の増加をもたらしています。例えば、世界保健機関(WHO)(2023)が提供したデータによると、毎年、世界中で約1億9,000万人が子宮内膜症の影響を受けています。Global Cancer Observatoryが提供する別のデータセットでは、2020年、前立腺がんは世界で4番目に罹患率の高いがんであり、約141万4,259人の新規患者が発生しています。従来の放射状前立腺摘除術は開腹手術でいたが、熟練した泌尿器科医にとってもいくつかの限界がありました。
手術用ロボットシステムのようなMISアプローチは、その精度と周囲の生体構造への最小限の侵襲のために人気を集めています。さらに、手術用ロボットシステムは、精度と正確さ、さらに患者の早期回復に役立つ肯定的な手術結果を再現できる可能性が高いという利点があるため、外科医が多くの外科手術を実施する際に好まれています。したがって、手術用ロボットシステム市場は、上記の要因により、予測期間に大幅な成長を記録する見込みです。
しかし、これらのシステムの大きな設計や、デバイスの高いコスト、潜在的な機械的制約が手術用ロボットシステム市場の成長を抑制する可能性があります。
手術用ロボットシステム市場は、COVID-19の拡大を抑制するために必要な措置としてロックダウン規制が実施されたため、一時的な後退期を経験しました。ロックダウンの主な影響の1つは、世界中の生産プロセスとサプライチェーンの混乱でした。前述の要因に加え、COVID-19に関連する患者負担の優先による医療処置の大幅な減少により、製品需要も大幅に減少しました。しかし、世界中で各種ワクチンが承認され投与され、医療サービスなどのさまざまな分野で平常を取り戻しつつあることから、手術用ロボットシステム市場は回復段階にあり、手術用ロボットシステム市場にとって有利な成長環境を示しています。
手術用ロボットシステム市場のセグメント分析
手術用ロボットシステム市場の用途セグメントでは、神経手術カテゴリが予測期間に市場で大きなCAGR成長を占める可能性があります。これは、神経手術における外科的介入へのニーズの高まりによるものと考えられます。脳腫瘍や脊髄腫瘍の有病率の上昇は、神経手術におけるロボットシステムの人気が高まっている主な理由の1つです。
当レポートでは、世界の手術用ロボットシステム市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。
Surgical Robotic Systems Market By Application (Urology, Gynecology, Neurosurgery, Orthopedics, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), And by geography is estimated to register appreciable CAGR forecast till 2030 owing to increase in surgical procedures and rising popularity of minimally invasive surgical interventions
Global Surgical Robotic Systems market was valued at USD 5.02 billion in 2023, growing at a CAGR of 11.50% during the forecast period from 2024 to 2030 to reach USD 9.64 billion by 2030. The demand for Surgical Robotic Systems is witnessing a surge due to increasing surgical procedures which can be attributed to various factors such as increasing geriatric population who form a big part of at-risk population for prostate cancer, valvular diseases, endometriosis among other diseases, growing need for robot-assisted surgery systems due to the growing inclination towards minimally invasive surgical approaches, and the innovation in product development which is paving the way for miniaturized surgical robots ultimately contributing in the overall growth of the Surgical Robotic Systems market during the forecast period from 2024-2030.
Surgical Robotic Systems Market Dynamics:
The Surgical Robotic Systems market is witnessing a surge in product demand due to growing popularity of minimally invasive procedures. Even though open surgeries are still a norm, the disadvantages associated with open surgery such as increased risk of procedural complications, longer healing time acted as a catalyst in the development of minimally invasive Surgical Robotic Systems. Surgical robots offer accuracy, stability, integration with modern imaging technology, greater range of motion, telesurgery, in addition to multiple other benefits exclusive to individual surgical specialties. Although endoscopy helped in overcoming limitations of open surgery however this technique also presented some challenges such as limited line of sight which were further overcome by Surgical Robotic Systems. These systems including the da Vinci, the AESOP, and ZEUS systems, provide surgeons with technologically advanced vision and hand skills. As a result, such systems are expected to revolutionize the field of surgery. Thus, owing to the advantages associated with surgical robots in the medical field, the growth prospect of the Surgical Robotic Systems market appears to be lucrative during the forecast period from 2024-2030.
Furthermore, the rising prevalence of various diseases such as gynecological problems including endometriosis, urological problems such as prostate cancer, and cardiovascular disorders such as mitral valve disease are also resulting in growing number of surgical interventions. For instance, as per the data provided by the World Health Organization (2023), each year, approximately 190 million across the globe are affected by endometriosis. In another dataset provided by the Global Cancer Observatory, in 2020, prostate cancer was the fourth most prevalent cancer in the world contributing about 1,414,259 new cases. Even though the conventional approach for radial prostatectomy in an open surgery procedure, it poses several limitations even for skilled urologists.
MIS approaches such as Surgical Robotic Systems are gaining popularity owing to their precision and minimally invasion in the surrounding anatomy. Furthermore, Surgical Robotic Systems are being preferred by surgeons for conducting numerous surgical procedures due to aided benefits of precision and accuracy and better chances of reproducing positive surgical outcomes which further helps in faster recovery for patients. Therefore, the Surgical Robotic Systems market is slated to register remarkable growth during the forecast period owing to the factors mentioned above.
However, bulky design of these systems, high cost of devices, and potential mechanical limitations may restrict the Surgical Robotic Systems market growth.
The Surgical Robotic Systems market witnessed a period of temporary recession as lockdown restrictions were enforced as a necessary step to curb the spread of COVID-19 infections. One of the major impacts of lockdowns were observed in the disruption of production process and supply chains across the globe. In addition to the previously mentioned factor, the significant reduction in the medical procedures due to the prioritization of the patient load associated with the COVID-19 infection, the demand for products also decreased significantly. However, with the approval and administration of various vaccines around the world, the Surgical Robotic Systems market is in the recovery stage, as the world has returned to normalcy in various areas such as medical services thereby presenting a positive growth environment for the Surgical Robotic Systems market.
Surgical Robotic Systems Market Segment Analysis:
Surgical Robotic Systems Market by Application (Urology, Gynecology, Neurosurgery, Orthopedics, and Others), by End User (Hospitals, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the application segment of the Surgical Robotic Systems market, the neurosurgery category may account for a remarkable CAGR growth in the Surgical Robotic Systems market during the forecast period. This can be ascribed to the growing need for surgical intervention in neurosurgery. Rising prevalence of brain and spinal cord tumors is one of the key reasons behind the growing popularity of robotic systems in neurosurgery.
Stereotactic neurosurgery has gained momentum as an active research field because it allows for targeting and treatment of intracranial lesions which were really challenging to treat in the past. For instance, neuromate stereotactic robot by Renishaw plc has been employed in numerous electrode implantation procedures for stereoelectroencephalography (SEEG), deep brain stimulation (DBS), as well as stereotactic applications in biopsy, neuro-endoscopy, and many other research applications. Thus the factors mentioned above are expected to drive the demand for Surgical Robotic Systems in coming years as more products become commercially available ultimately driving the Surgical Robotic Systems market forward.
North America is expected to dominate the overall Surgical Robotic Systems Market:
Among all the regions, North America is estimated to account for the dominant share in the Surgical Robotic Systems market. Owing to significance of key growth factors such as rising growing prevalence of cancers, increasing prevalence of degenerative bone disorders, and rising government initiatives regarding disease treatment awareness, the North America Surgical Robotic Systems market is expected to register positive growth. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and high awareness also helped the market growth in this region.
One of the key reasons positively influencing the growth of the United States Surgical Robotic Systems market is the rising prevalence of cancers in the US population. As per the latest data provided by American Cancer Society, in 2022, about 1.9 million new cancer cases diagnosed and 608,570 cancer deaths were estimated to occur in the United States. For instance, according to the National Cancer Institute, in 2022, near about 149,500 new cases and 52,980 deaths due to colorectal cancer were estimated to occur in the United States. Cancer surgeries can be extremely daunting for surgeons as they can stretch for extended hours wherein surgeons' attention and precision may be compromised due to fatigue. Therefore, the rising prevalence of cancers in the country is expected to aid in the growing need for medical robots thereby aiding in the growth of the United States Surgical Robotic Systems market.
Another key aspect that influenced the United States Surgical Robotic Systems market was the well-established healthcare infrastructure in the country. United States is considered as one of the most technologically-forward nations in the world and has the reputation of providing world-class healthcare facilities to patients. As per the data cited by Intuitive Surgical Inc, they made maximum sales of their surgical robots in the United States. Moreover, the country provides a lucrative growth environment for manufacturers in terms of technology development, regulatory framework, and product sales thereby contributing in high product demand.
Furthermore, the presence of large patient pool, and extensive insurance coverage also motivates patients to opt for surgical interventions in the country which further is contributing in the demand for robot-assisted surgical systems. For instance, a South Korea-based company, Koh Young Technology Inc is planning to launch a neurosurgical robotics system in the US market by 2022 after it receives the approval from the US Food and Drug Administration. Thus, all the factors mentioned above collectively contribute in the local demand for products ultimately driving the United States surgical robots market in the forecast period.
Surgical Robotic Systems Market Key Players:
Some of the key Surgical Robotic System Companies operating in the market includes Intuitive Surgical Inc, Stryker, JOHNSON & JOHNSON MEDICAL DEVICES COMPANIES, Medtronic, avateramedical GmbH, CMR Surgical Ltd., Medicaroid Corporation, Medrobotics Corp, Asensus Surgical US, Inc, Globus Medical, Microport Scientific Corporation, Smith & Nephew PLC., Accuray Incorporated, THINK Surgical., Renishaw plc, Zimmer Biomet, Corindus, Inc (Siemens Healthineers), Preceyes BV., MicroSure, Memic Innovative Surgery Ltd and others.
Recent Developmental Activities in Surgical Robotic Systems Market:
In November 2022, Brain Navi Biotaechnology, a Taiwan-based company received the CE (Conformite Europeenne) Mark for their NaoTrac, a robotic-assisted surgical robot.
In October 2022, Medtronic received the CE (Conformite Europeenne) Mark for their Hugo(TM) robotic-assisted surgery (RAS) system thereby enabling Medtronic to access European market for this device. The device received the approval for gynecologic and urological procedures.
In March 2022, an Israel-based company Memic Innovative Surgery received the regulatory approval from the US Food and Drug Administration for their robotically-assisted surgical device, making it the first FDA-approved surgical robotic devices for transvaginal hysterectomy.
Key Takeaways from the Surgical Robotic Systems Market Report Study
Market size analysis for current Surgical Robotic Systems market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Surgical Robotic Systems market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global Surgical Robotic Systems Market Landscape.
Various opportunities available for the other competitor in the Surgical Robotic Systems Market space.
What are the top performing segments in 2023? How these segments will perform in 2030.
Which is the top-performing regions and countries in the current Surgical Robotic Systems market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Surgical Robotic Systems market growth in the coming future?
Target Audience who can be benefited from this Surgical Robotic Systems Market Report Study
Surgical Robotic Systems products providers
Research organizations and consulting companies
Surgical Robotic Systems-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in Surgical Robotic Systems
Various End-users who want to know more about the Surgical Robotic Systems market and latest technological developments in the Surgical Robotic Systems market.
Frequently Asked Questions for Surgical Robotic Systems Market:
Surgical Robotic Systems, also known as robot-assisted surgical devices are medical devices that are computer-assisted systems which are employed in surgical navigation, pre-operative planning, and also assist in carrying out surgical procedures in a minimally invasive manner.
Global Surgical Robotic Systems market was valued at USD 5.02 billion in 2023, growing at a CAGR of 11.50% during the forecast period from 2024 to 2030 to reach USD 9.64 billion by 2030.
The demand for Surgical Robotic Systems is witnessing a surge due to increasing surgical procedures which can be attributed to various factors such as increasing geriatric population who form a big part of at-risk population for prostate cancer, valvular diseases, endometriosis among others, growing need for robot-assisted surgery systems due to the growing inclination towards minimally invasive surgical approaches, and the innovation in product development which is paving the way for miniaturized surgical robots ultimately contributing in the overall growth of the Surgical Robotic Systems market during the forecast period from 2024-2030.
Some of the key market players operating in the Surgical Robotic Systems market includes Intuitive Surgical Inc, Stryker, JOHNSON & JOHNSON MEDICAL DEVICES COMPANIES, Medtronic, avateramedical GmbH, CMR Surgical Ltd., Medicaroid Corporation, Medrobotics Corp, Asensus Surgical US, Inc, Globus Medical, Microport Scientific Corporation, Smith & Nephew PLC., Accuray Incorporated, THINK Surgical., Renishaw plc, Zimmer Biomet, Corindus, Inc (Siemens Healthineers), Preceyes BV., MicroSure, Memic Innovative Surgery Ltd and others.
North America is expected to dominate the overall Surgical Robotic Systems market during the forecast period, 2024 to 2030. Owing to significance of key growth factors such as rising growing prevalence of cancers, increasing prevalence of degenerative bone disorders, and rising government initiatives regarding disease treatment awareness, the North America Surgical Robotic Systems market is expected to register positive growth. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and high awareness also helped the market growth in this region.